2024 HCPCS Code Q2042
Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
TAGS: viable preparation leukapheresis therapeutic million
Short Description | Tisagenlecleucel car-pos t |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 01, 2019 |
HCPCS Code Added Date | January 01, 2019 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q4121 - Theraskin
- Q4122 - Dermacell, awm, porous sq cm
- Q4123 - Alloskin
- Q4124 - Oasis tri-layer wound matrix
- Q4125 - Arthroflex
- Q4126 - Memoderm/derma/tranz/integup
- Q4127 - Talymed
- Q4128 - Flexhd/allopatchhd/sq cm
- Q4129 - Unite biomatrix
- Q4130 - Strattice tm
- Q4131 - Epifix or epicord
- Q4132 - Grafix core, grafixpl core
- Q4133 - Grafix stravix prime pl sqcm
- Q4134 - Hmatrix
- Q4135 - Mediskin
- Q4136 - Ezderm
- Q4137 - Amnioexcel biodexcel 1sq cm
- Q4138 - Biodfence dryflex, 1cm
- Q4139 - Amnio or biodmatrix, inj 1cc
- Q4140 - Biodfence 1cm